<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An increasing number of reports suggest the involvement of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> where the increased formation of reactive oxygen species (ROS) leads to neuronal damage and cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="40" ids="18243">Dopamine</z:chebi> may contribute to <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> such as <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced damage </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="25375">Monoamine</z:chebi> oxidase (MAO) enzyme (particularly MAO-B) is responsible for metabolizing <z:chebi fb="40" ids="18243">dopamine</z:chebi> and plays an important role in <z:mp ids='MP_0003674'>oxidative stress</z:mp> through altering the redox state of neuronal and glial cells </plain></SENT>
<SENT sid="3" pm="."><plain>MAO participates in the generation of <z:chebi fb="1" ids="29191">hydroxyl radicals</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>This suggests the possible use of MAO inhibitors as neuroprotective agents for treating ischemic injury </plain></SENT>
<SENT sid="5" pm="."><plain>The protective effect of deprenyl (N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-N-(1-<z:chebi fb="36" ids="29309">methyl</z:chebi>-2-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-ethyl)-prop-2-yn-1-<z:chebi fb="39" ids="32952">amine</z:chebi>, CAS 14611-51-9) (2 and 10 mg/kg), a MAO-B inhibitor, and <z:chebi fb="9" ids="17579">beta-carotene</z:chebi> (10 and 20 mg/kg), a natural <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, was examined in a rat model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> was induced in rats by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 1 h followed by declamping for another hour </plain></SENT>
<SENT sid="7" pm="."><plain>The effect of the drugs on the brain activity of <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH) and some of the <z:mp ids='MP_0003674'>oxidative stress</z:mp> biomarkers such as brain activity of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and catalase (CAT) enzymes and brain malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) content was determined </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, the content of <z:chebi fb="2" ids="33567">catecholamines</z:chebi> such as <z:chebi fb="15" ids="33569">noradrenaline</z:chebi> (NA) and <z:chebi fb="40" ids="18243">dopamine</z:chebi> (<z:mp ids='MP_0000273'>DA</z:mp>) was determined </plain></SENT>
<SENT sid="9" pm="."><plain>Deprenyl decreased the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced elevation of LDH activity and <z:chebi fb="14" ids="32506">MDA</z:chebi> content and normalized the SOD activity </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, deprenyl increased the CAT activity back to <z:mpath ids='MPATH_458'>normal</z:mpath>, and increased the <z:chebi fb="15" ids="33569">noradrenaline</z:chebi> and <z:chebi fb="40" ids="18243">dopamine</z:chebi> content in the brain of rats </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="9" ids="17579">Beta-carotene</z:chebi> administration ameliorated the effect of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by reperfusion (I/R) demonstrated as decreasing the LDH activity and <z:chebi fb="14" ids="32506">MDA</z:chebi> content and by increasing the SOD activity </plain></SENT>
<SENT sid="12" pm="."><plain>The drug also <z:mp ids='MP_0011593'>increased CAT</z:mp> activity in the brain of rats </plain></SENT>
<SENT sid="13" pm="."><plain>However, <z:chebi fb="9" ids="17579">beta-carotene</z:chebi> did not alter the NA and <z:mp ids='MP_0000273'>DA</z:mp> content </plain></SENT>
<SENT sid="14" pm="."><plain>These results indicate that deprenyl protected the rat brains against the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced oxidative damage, an effect which might be explained through multiple mechanisms, possibly due to reduction of <z:chebi fb="40" ids="18243">dopamine</z:chebi> catabolism with a subsequent increased activity on dopaminergic D2 receptors and suppressing the action of ROS as well </plain></SENT>
</text></document>